Search Results - "Palmieri, Giovannella"
-
1
Hepatocellular carcinoma: Will novel targeted drugs really impact the next future?
Published in World journal of gastroenterology : WJG (21-07-2016)“…Cancer treatment has been revolutionized by the advent of new molecular targeted and immunotherapeutic agents. Identification of the role of tumor angiogenesis…”
Get full text
Journal Article -
2
BRAF Gene and Melanoma: Back to the Future
Published in International journal of molecular sciences (27-03-2021)“…As widely acknowledged, 40-50% of all melanoma patients harbour an activating BRAF mutation (mostly BRAF V600E). The identification of the RAS-RAF-MEK-ERK (MAP…”
Get full text
Journal Article -
3
Case report: Potential role of immunotherapy in thymic malignancies: a unique case of a durable and complete response upon an immune checkpoint inhibitor
Published in Frontiers in immunology (03-07-2024)“…Thymic epithelial tumors are rare malignancies with an incidence of 1.7 cases per million people per year. They pose significant management challenges due to…”
Get full text
Journal Article -
4
COVID-19 in patients with thymic epithelial tumors with or without Good's syndrome: a single-center retrospective study
Published in BMC cancer (19-06-2024)“…Thymic epithelial tumors (TETs) are rare neoplasms often associated with immune-related disorders. Patients with Good's syndrome (GS), an adult-acquired…”
Get full text
Journal Article -
5
Immunocytometric analysis of patients with thymic epithelial tumors revealed that COVID-19 vaccine booster strongly enhanced the immune response
Published in Frontiers in immunology (29-08-2023)“…Background Thymic epithelial tumors (TETs) are rare malignancies with heterogeneous clinical manifestations. The high frequency of autoimmune paraneoplastic…”
Get full text
Journal Article -
6
Sorafenib in advanced iodine-refractory differentiated thyroid cancer: efficacy, safety and exploratory analysis of role of serum thyroglobulin and FDG-PET
Published in Clinical endocrinology (Oxford) (01-05-2013)“…Summary Context Radioactive iodine is a crucial tool for treatment of differentiated thyroid cancer (DTC). In 5% of cases, DTCs lose I‐131 avidity and assume…”
Get full text
Journal Article -
7
Extraskeletal Ewing's sarcoma of the mediastinum: Case report
Published in Frontiers in oncology (26-01-2023)“…Ewing sarcoma (ES) represents the second most common malignant bone tumor in children and young adults. ES is not a frequent finding in sites different from…”
Get full text
Journal Article -
8
Immunological signature of patients with thymic epithelial tumors and Good syndrome
Published in Frontiers in immunology (18-08-2022)“…Background Thymic epithelial tumors (TETs) are frequently accompanied by Good Syndrome (GS), a rare immunodeficiency, characterized by hypogammaglobulinemia…”
Get full text
Journal Article -
9
Phase II Study of Sorafenib in Patients With Sunitinib-Refractory Metastatic Renal Cell Cancer
Published in Journal of clinical oncology (20-09-2009)“…No previous prospective trials have been reported with sorafenib in patients with sunitinib-refractory metastatic renal cell cancer (MRCC). We conducted a…”
Get full text
Journal Article -
10
The Enigmatic Role of TP53 in Germ Cell Tumours: Are We Missing Something?
Published in International journal of molecular sciences (02-07-2021)“…The cure rate of germ cell tumours (GCTs) has significantly increased from the late 1970s since the introduction of cisplatin-based therapy, which to date…”
Get full text
Journal Article -
11
A comprehensive outlook on intracerebral therapy of malignant gliomas
Published in Critical reviews in oncology/hematology (01-10-2011)“…Abstract Glioblastoma multiforme (GBM) is the most frequent and aggressive malignant glioma (MG), with a median survival time of 12–15 months, despite current…”
Get full text
Journal Article -
12
Shifting from a Biological-Agnostic Approach to a Molecular-Driven Strategy in Rare Cancers: Ewing Sarcoma Archetype
Published in Biomedicines (01-03-2023)“…Sarcomas of the thoracic cavity are rare entities that predominantly affect children and young adults. They can be very heterogeneous encompassing several…”
Get full text
Journal Article -
13
Results of TETimaX Trial of Langerhans Cell Histiocytosis Treatment and Perspectives on the Role of Imatinib Mesylate in the Era of MAPK Signaling
Published in Biomedicines (24-11-2021)“…Langerhans cell histiocytosis (LCH) is a rare disease that has a variable clinical presentation and unpredictable behavior. Until recently, therapeutic options…”
Get full text
Journal Article -
14
A New Horizon of Liquid Biopsy in Thymic Epithelial Tumors: The Potential Utility of Circulating Cell-Free DNA
Published in Frontiers in oncology (04-02-2021)“…Thymic epithelial tumors (TETs) are rare thoracic malignancies, commonly divided into two different histopathological entities, thymoma (T) and thymic…”
Get full text
Journal Article -
15
Large retroperitoneal lymphadenopathy and increased risk of venous thromboembolism in patients receiving first‐line chemotherapy for metastatic germ cell tumors: A study by the global germ cell cancer group (G3)
Published in Cancer medicine (Malden, MA) (01-01-2020)“…Background Metastatic germ cell tumor (mGCT) patients receiving chemotherapy have increased risk of life‐threatening venous thromboembolism (VTE). Identifying…”
Get full text
Journal Article -
16
Efficacy of rituximab in gastric diffuse large B cell lymphoma patients
Published in World journal of gastroenterology : WJG (28-05-2010)“…AIM:To evaluate retrospectively the efficacy of rituximab plus chemotherapy in gastric diffuse large B cell lymphoma(DLBCL).METHODS:Sixty patients(median…”
Get full text
Journal Article -
17
Thymic Epithelial Tumors as a Model of Networking: Development of a Synergistic Strategy for Clinical and Translational Research Purposes
Published in Frontiers in oncology (14-07-2020)“…Among the group of thymic epithelial tumors (TET), thymomas often show either uncertain or explicit malignant biological behavior, local invasiveness, and…”
Get full text
Journal Article -
18
Peg-filgrastim and cabazitaxel in prostate cancer patients
Published in Anti-cancer drugs (01-01-2013)“…To determine the impact of prophylaxis with granulocyte-colony stimulating growth factor (G-CSF) on the risk of febrile neutropenia in a cohort of patients…”
Get full text
Journal Article -
19
Cetuximab is an active treatment of metastatic and chemorefractory thymoma
Published in Frontiers in bioscience (01-01-2007)“…Advanced chemorefractory thymic epithelial tumors still represent a challenge in clinical oncology. A rationale-based therapeutic approach targeting a key…”
Get full text
Journal Article -
20
Zoledronic acid in treatment of bone lesions by Langerhans cell histiocytosis
Published in Journal of bone and mineral metabolism (01-01-2009)“…Langerhans cell histiocytosis (LCH) is a rare disease, probably an atypical myeloproliferative syndrome, with variable clinical presentation and behavior. In…”
Get full text
Journal Article